[1]張軍濤.對比劑急性腎損傷的診治[J].醫學信息,2020,(04):62-65.[doi:10.3969/j.issn.1006-1959.2020.04.019]
 ZHANG Jun-tao.Diagnosis and Treatment of Acute Kidney Injury with Contrast Agent[J].Medical Information,2020,(04):62-65.[doi:10.3969/j.issn.1006-1959.2020.04.019]
點擊復制

對比劑急性腎損傷的診治()
分享到:

醫學信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期數:
2020年04期
頁碼:
62-65
欄目:
綜述
出版日期:
2020-02-15

文章信息/Info

Title:
Diagnosis and Treatment of Acute Kidney Injury with Contrast Agent
文章編號:
1006-1959(2020)04-0062-04
作者:
張軍濤
(天津市武清區人民醫院心內科,天津 301700)
Author(s):
ZHANG Jun-tao
(Department of Cardiology,People’s Hospital of Wuqing District,Tianjin 301700,China)
關鍵詞:
對比劑急性腎損傷危險因素防治策略
Keywords:
Contrast agentAcute kidney injuryRisk factorsPrevention strategy
分類號:
R692
DOI:
10.3969/j.issn.1006-1959.2020.04.019
文獻標志碼:
A
摘要:
對比劑急性腎損傷是臨床上急性腎損傷常見的病因之一,該病并不完全可逆,可進展為慢性腎病,延長住院時間,增加住院費用,發生不良事件以及死亡風險增加。對比劑急性腎損傷的病理生理學機制尚未完全明確,預防策略也存在爭議。本文就近年來對比劑急性腎損傷的診斷標準、發病機制、危險因素及防治策略等進行綜述。
Abstract:
Contrast-induced acute kidney injury is one of the common causes of acute kidney injury in the clinic. The disease is not completely reversible. It can progress to chronic kidney disease, prolong hospital stays, increase hospitalization costs, increase adverse events, and increase the risk of death. The pathophysiological mechanism of contrast-induced acute kidney injury has not been fully defined, and the prevention strategy is also controversial. This article reviews the diagnostic criteria, pathogenesis, risk factors and prevention strategies of acute kidney injury in contrast media in recent years.

參考文獻/References:

[1]Fahling M,Seeliger E,Patzak A.Understanding and preventing contrast-induced acute kidney injury[J].Nat Rev Nephrol,2017,13(3):169-180. [2]Hami M,Bigdeli A,Khameneh Bagheri R,et al.The effect of curcumin in prevention of contrast nephropathy following coronary angiography or angioplasty in CKD patients[J].Iran J Kidney Dis,2019(13):304-309. [3]Giacoppo D,Gargiulo G,Buccheri S,et al.Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures:Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28240 Patients[J].Circ Cardiovasc Interv,2017,10(5):e00438. [4]Mehran R,Dangas GD.Contrast-Associated Acute Kidney Injury[J].N Engl J Med,2019(380):2146-2155. [5]Shukla AN,Juneja M,Patel H,et al.Diagnostic accuracy of serum cystatin C for early recognition of contrast induced nephropathy in Western Indians undergoing cardiac catheterization[J].Indian Heart J,2017,69(3):311-315. [6]Mamoulakis C,Tsarouhas K,Fragkiadoulaki I,et al.Contrast-induced nephropathy: basic concepts, pathophysiological implications and prevention strategies[J].Pharmacol Ther,2017(180):99-112. [7]Naziroglu M,Yoldas N,Uzgur ENL,et al.Role of contrast media on oxidative stress,Ca(2+) signaling and apoptosis in kidney[J].J Membr Biol,2013,246(2):91-100. [8]Mehran R,Dangas GD.Contrast-Associated Acute Kidney Injury.Reply[J].N Engl J Med,2019(381):1296-1297. [9]Liu ZZ,Schmerbach K,Lu Y,et al.Iodinated contrast media cause direct tubular cell damage, leading to oxidative stress,low nitric oxide,and impairment of tubuloglomerular feedback[J].Am J Physiol Renal Physiol,2014,306(8):F864-F872. [10]Morcos R,Kucharik M,Bansal P,et al.Contrast-Induced Acute Kidney Injury:Review and Practical Update[J].Clin Med Insights Cardiol,2019(13):1179546819878680. [11]Andreucci M,Faga T,Pisani A,et al.Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors[J].Scientific World Journal,2014(2014):823169. [12]Tsarouhas K,Tsitsimpikou C,Papantoni X,et al.Oxidative stress and kidney injury in trans-radial catheterization[J].Biomed Rep,2018(8):417-425. [13]Jorgensen AL.Contrast-induced nephropathy:pathophysiology and preventive strategies[J].Crit Care Nurse,2013,33(1):37-46. [14]Andreucci M,Faga T,Pisani A,et al.Acute kidney injury by radiographic contrast media: pathogenesis and prevention[J].Biomed Res Int,2014(2014):362725. [15]Azzalini L,Spagnoli V,Ly HQ.Contrast-induced nephropathy:from pathophysiology to preventive strategies[J].Can J Cardiol,2016,32(2):247-255. [16]McCullough PA,Choi JP,Feghali GA,et al.Contrast-induced acute kidney injury[J].J Am Coll Cardiol,2016,68(13):1465-1473. [17]Andò G,Cortese B,Russo F,et al.Acute kidney injury after radial or femoral access for invasive acute coronary syndrome management:AKI-MATRIX[J].J Am Coll Cardiol,2017,69(21):2592-2603. [18]Meinel FG,De Cecco CN,Schoepf UJ,et al.Contrast-induced acute kidney injury:definition, epidemiology,and outcome[J].Biomed Res Int,2014(2014):859328. [19]Neyra JA,Shah S,Mooney R,et al.Contrast-induced acute kidney injury following coronary angiography:a cohort study of hospitalized patients with or without chronic kidney disease[J].Nephrol Dial Transplant,2013,28(6):1463-1471. [20]Tan H,Yi H,Zhao W,et al.Intraglomerular crosstalk?elaborately regulates podocyte injury and repair in diabetic patients:insights from a 3D multiscale modeling study[J].Oncotarget,2016,7(45):73130-73146. [21]Han XF,Zhang XX,Liu KM,et al.Contrast-induced nephropathy in patients with diabetes mellitus between iso- and low-osmolar contrast media:A meta-analysis of full-text prospective,randomized controlled trials[J].PLoS One,2018,13(3):e0194330. [22]Hossain MA,Costanzo E,Cosentino J,et al.Contrast-induced nephropathy: Pathophysiology,risk factors,and prevention[J].Saudi J Kidney Dis Transpl,2018,29(1):1-9. [23]Heyman SN,Rosenberger C,Rosen S.Why is diabetes mellitus a risk factor for contrast-induced nephropathy[J].Biomed Res Int,2013(2013):123589. [24]Jurado-Román A,Hernández-Hernández F,García-Tejada J,et al.Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention[J].Am J Cardiol,2015,115(9):1174-1178. [25]Subramaniam RM,Suarez-Cuervo C,Wilson RF,et al.Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy:A Systematic Review and Meta-analysis[J].Ann Intern Med,2016,164(6):406-416. [26]Cernigliaro JG,Haley WE,Adolphson DP,et al.Contrast-induced nephropathy in outpatients with preexisting renal impairment:a comparison between intravenous iohexol and iodixanol[J].Clin Imaging,2016,40(5):902-906. [27]Cheng W,Zhao F,Tang CY,et al.Comparison of iohexol and iodixanol induced nephrotoxicity, mitochondrial damage and mitophagy in a new contrast-induced acute kidney injury rat model[J].Arch Toxico,2018(92):2245-2257. [28]王心鏡,劉平玲,曹雪,等.造影劑溫度對經皮冠狀動脈介入治療患者造影劑腎病發病率的影響[J].心臟雜志,2017,29(2):198-201. [29]Malik A.Prevention of contrast-induced acute kidney injury[J].Br J Hosp Med(Lond)2015,76(12):685-689. [30]Tsai TT,Patel UD,Chang TI,et al.Contemporary incidence,predictors,and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions:insights from the NCDR Cath-PCI registry[J].J Am Coll Cardiol Intv,2014,7(1):1-9. [31]Maioli M,Toso A,Leoncini M,et al.Bioimpedance-guided hydration for the prevention of contrast-induced kidney injury:the HYDRA study[J].J Am Coll Cardiol,2018(71):2880-2889. [32]中華醫學會心血管病學分會介入心臟病學組,中國醫師協會心血管內科醫師分會血栓防治專業委員會,中華心血管病雜志編輯委員會.中國經皮冠狀動脈介入治療指南(2016)[J].中華心血管病雜志,2016,44(5):382-400. [33]Matsunami T,Hino K,Dosho R,et al.Efficacy of oral supplemental hydration for the prevention of contrast-induced nephropathy in rats[J].Jpn J Radiol,2017,35(4):190-196. [34]Pakfetrat M,Malekmakan L,Salmanpour Z,et al.Comparison of Normal Saline, Ringer’s Lactate, and Sodium Bicarbonate for Prevention of Contrast-induced Nephropathy in Patients with Coronary Angiography:A Randomized Double-blind Clinical Trial[J].Indian J Nephrol,2019(29):22-27. [35]Martin-Moreno PL,Varo N,Martínez-Ansó E,et al.Comparison of Intravenous and Oral Hydration in the Prevention of Contrast-Induced Acute Kidney Injury in Low-Risk Patients:A Randomized Trial[J].Nephron,2015,131(1):51-58. [36]Biernacka-Fialkowska B,Szuksztul M,Suslik W,et al.Intravenous N-acetylcysteine for the PReventionOf Contrast-induced nephropathy-a prospective,single-center,randomized, placebo-controlled trial.The INPROC trial[J].Postepy Kardiol Interwencyjnej,2018,14(1):59-66. [37]Inda-Filho AJ,Caixeta A,Manggini M.Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury?A randomized controlled trial[J].PLoS One,2014(9):e107602. [38]Gandhi S,Mosleh W,Abdel-Qadir H.Statins and contrast-induced acute kidney injury with coronary angiography[J].Am J Med 2014,127(10):987-1000. [39]Chanin JM,Yang DC,Haider MA,et al.Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention[J].J Invasive Cardiol,2015,27(11):490-496. [40]Anjum I,Akmal M,Hasnain N,et al.Statins role in preventing contrast-induced acute kidney injury:a scoping review[J].Hong Kong Med J,2019,25(3):216-221. [41]Arabmomeni M,Najafian J,Abdar Esfahani M,et al.Comparison between theophylline, N-acetylcysteine,and theophylline plus N-acetylcysteine for the prevention of contrast-induced nephropathy[J].ARYA Atheroscler,2015,11(1):43-49. [42]Dai B,Liu Y,Fu L,et al.Effect of theophylline on prevention of contrast-induced acute kidney injury:a meta-analysis of randomized controlled trials[J].Am J Kidney Dis,2012,60(3):360-370. [43]Cruz DN,Goh CY,Marenzi G,et al.Renal replacement therapies for prevention of radiocontrastinduced nephropathy:a systematic review[J].Am J Med,2012,125(1):66-78.e3.

相似文獻/References:

[1]朱姝華.不同對比劑濃度對能譜CT冠脈成像的影響研究[J].醫學信息,2018,(08):157.[doi:10.3969/j.issn.1006-1959.2018.08.055]
 ZHU Shu-hua.Effect of Different Concentration of Contrast Medium on Coronary Angiography with Energy Dispersive CT[J].Medical Information,2018,(04):157.[doi:10.3969/j.issn.1006-1959.2018.08.055]
[2]黨 陽.急性腎損傷早期診斷標志物的研究進展[J].醫學信息,2018,(11):43.[doi:10.3969/j.issn.1006-1959.2018.11.014]
 DANG Yang.Research Progress on Markers for Early Diagnosis of Acute Kidney Injury[J].Medical Information,2018,(04):43.[doi:10.3969/j.issn.1006-1959.2018.11.014]
[3]傅 君,吳偉芳.CRRT治療應用于危重急性腎損傷對患者 腎功能及病死率的影響[J].醫學信息,2019,(17):104.[doi:10.3969/j.issn.1006-1959.2019.17.033]
 FU Jun,WU Wei-fang.Effect of CRRT Treatment on Renal Function and Mortality in Patients with Critical Acute Kidney Injury[J].Medical Information,2019,(04):104.[doi:10.3969/j.issn.1006-1959.2019.17.033]
[4]張建強,蔣 鵬,顧新偉,等.公民逝世后器官捐獻合并AKI供體腎移植的療效觀察[J].醫學信息,2019,(12):96.[doi:10.3969/j.issn.1006-1959.2019.12.029]
 ZHANG Jian-qiang,JIANG Peng,GU Xin-wei,et al.Therapeutic Effect of Organ Donation Combined with AKI Donor Kidney Transplantation after the Death of Citizens[J].Medical Information,2019,(04):96.[doi:10.3969/j.issn.1006-1959.2019.12.029]
[5]陳冀遠.右美托咪啶對膿毒癥急性腎損傷患者腎功能及血管緊張素Ⅱ表達的影響[J].醫學信息,2020,(01):142.[doi:10.3969/j.issn.1006-1959.2020.01.045]
 CHEN Ji-yuan.Effect of Dexmedetomidine on Renal Function and Angiotensin Ⅱ Expression in Patients with Acute Renal Injury in Sepsis[J].Medical Information,2020,(04):142.[doi:10.3969/j.issn.1006-1959.2020.01.045]
[6]白 準,劉旭麗,曾維忠,等.持續腎臟替代治療時機對感染性休克合并急性腎損傷患者預后的影響[J].醫學信息,2020,(08):116.[doi:10.3969/j.issn.1006-1959.2020.08.036]
 BAI Zhun,LIU Xu-li,ZENG Wei-zhong,et al.Effect of Continuous Renal Replacement Therapy on the Prognosis of Patients with Septic Shock and Acute Kidney Injury[J].Medical Information,2020,(04):116.[doi:10.3969/j.issn.1006-1959.2020.08.036]

更新日期/Last Update: 2020-02-15
中国足彩网竞彩 泰瑞信达 天津彩悦城儿童娱乐 湖北l1选5开奖结果 河南省快三开奖 赛岳恒配资 甘肃快3全天网页版计划 股票好论坛 股票指数买10股多少钱么计算的 快乐赛车预测 河北体彩11选五手机版